Research into the extracellular matrix is exploring new approaches to restoring soft tissue, with potential applications ranging from facial rejuvenation to post-weight-loss restoration and body contouring.
Johnny Franco, MD, FACS, discusses how implant removals, biologic innovation, and patient demand for long-term tissue health are accelerating a regenerative shift in body aesthetics.
FDA approves RHA Redensity Eye for correction of moderate to severe tissue volume deficiencies in the infraorbital region in adults ages 22 and older.
